The biotechnology recovery is not a farce. These 3 stocks could lead the next bullish leg
The stock market's attention has been focused almost exclusively on artificial intelligence, semiconductors and a handful of large-cap technology companies.…
business news
Cramer Says This Stock Is Significantly Undervalued And Sees 35% Upside
Every weekday, CNBC's Investment Club with Jim Cramer hosts a livestream “morning meeting” at 10:20 a.m. ET. Here's a recap…
Paramount-WBD merger expected to face lawsuits from states, sources say
Jakub Porzycki | Nurfoto | fake images A group of state attorneys general is expected to file a lawsuit Monday…
Employers Are Not Expanding Coverage of GLP-1 Anti-Obesity Drugs: Survey
A version of this article first appeared in CNBC's Healthy Returns newsletter, bringing the latest healthcare news directly to your…
AstraZeneca trial failure raises bigger questions about its portfolio
AstraZenecaWainua's failed final trial was never expected to have a major financial impact on the company. Most analysts estimate that…
Abivax receives $920 million in cash to prepare for US launch: CEO
AbivaxThe latest round of funding allows the biotech to move toward launching its intestinal disease drug in the United States…
Palm Beach airport in Florida changes its name in tribute to Trump
A welcome sign at Palm Beach International Airport, now renamed “President Donald J. Trump International Airport”, in West Palm Beach,…
AstraZeneca shares fall 9% after heart drug trial falls short of target
Actions of AstraZeneca fell as much as 9% after a late-stage clinical trial for a heart disease drug failed to…
Rivian Shares Fall 12% Amid Plans to Sell 75 Million Shares
A motherboard from one of Rivian's all-electric vehicles. Michael Wayland/CNBC Rivian Automotive Shares plunged nearly 15% in midday trading Tuesday…
Jim Cramer Says These Are the 5 Stocks to Buy During This Market Rotation
CNBC's Jim Cramer said Monday that investors should not fear the latest market rotation. Instead, he believes he is creating…